I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Apatinib combined with camrelizumab in the treatment of rec..:
Yunyan Mo
;
Yufei Pan
;
Bin Zhang
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1298418/full. , 2024
Link:
https://doi.org/10.3389/fimmu.2023.1298418
RT Journal T1 <Title>Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:cad5c6908aba4cd181d4fb1baa10c45b&Exemplar=1&LAN=DE A1 Yunyan Mo A1 Yufei Pan A1 Bin Zhang A1 Jian Zhang A1 Yixin Su A1 Zhengchun Liu A1 Meiqing Luo A1 Guanjie Qin A1 Xiangyun Kong A1 Rongjun Zhang A1 Yu Pan A1 Yi Liang A1 Defeng Wang A1 Yuejia Wei A1 Hengwei Chen A1 Wei Jiang PB Frontiers Media S.A. YR 2024 K1 nasopharyngeal carcinoma K1 clinical trial K1 immunotherapy K1 targeted therapy K1 apatinib K1 camrelizumab K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1298418/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1298418 DO https://doi.org/10.3389/fimmu.2023.1298418 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
